as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹32.71
Change
+0.1 (0.31%)
Open
₹32.4
Prev. Close
₹32.61
Day High
₹32.73
Day Low
₹32.3
Volume Analysis
Traded
218,791
Delivered
157,473
Delivery %
71.97%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹33.29 | ₹33.01 | ₹32.86 | ₹32.58 | ₹32.43 | ₹32.15 | ₹32.0 |
| Fibonacci | ₹33.01 | ₹32.85 | ₹32.74 | ₹32.58 | ₹32.42 | ₹32.31 | ₹32.15 |
| Camarilla | ₹32.83 | ₹32.79 | ₹32.75 | ₹32.58 | ₹32.67 | ₹32.63 | ₹32.59 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+0.21%
1 Week
-1.65%
1 Month
+11.11%
3 Months
-2.42%
6 Months
+1.71%
1 Year
+0.18%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Icicipramc-icicifin lands in the middle of the pack on TopFund's composite fundamentals check, at 55/100. The strongest factor is Risk & Volatility (59/100), while Liquidity (50/100) is the weakest area to weigh before deciding.
TopFund Score — Fundamentals Quality
55/100 — AverageData confidence: 56/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Which Mutual Funds Hold Icicipramc-icicifin?
Frequently Asked Questions about Icicipramc-icicifin
Icicipramc-icicifin (FINIETF) closed at ₹32.71 on NSE on 19 November 2026, up 0.1 (0.31%) from the previous close.
Icicipramc-icicifin trades on the NSE (National Stock Exchange of India) under the symbol FINIETF.
Icicipramc-icicifin has a TopFund Quality Score of 55/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Icicipramc-icicifin?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.